U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07401849) titled 'Blood Biomarkers for Early and Accurate Diagnosis of Alzheimer's Disease in Primary Care' on Jan. 20.
Brief Summary: Alzheimer's disease is a degenerative condition affecting the brain and is the most common form of dementia in older adults. Dementia is currently a major healthcare issue in the UK, affecting approximately a million people. The progression of the disease varies between individuals and the early stages may be characterised by only minimal changes in memory and thinking. These changes could remain undetected as the symptoms may be mistakenly regarded as normal age-related forgetfulness. However, dementia is not part of...